Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
272 stocks in Europe match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| 4BB.L | 4basebio PLC | Healthcare | $99.96M | 470.00 GBP | −48.91% | −10.48% |
| ABNX.PA | ABIONYX Pharma SA | Healthcare | $98.59M | 1.97 EUR | −62.68% | +5.79% |
| 88Q.DE | 4basebio PLC | Healthcare | $96.59M | 5.35 EUR | −46.50% | −3.60% |
| NANOFH.HE | Nanoform Finland Oyj | Healthcare | $95.78M | 0.96 EUR | −30.54% | +9.34% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| ADOC.PA | Adocia SA | Healthcare | $93.77M | 4.01 EUR | −67.66% | −0.20% |
| NANOFS.ST | Nanoform Finland Oyj | Healthcare | $93.63M | 10.94 SEK | −28.12% | +15.40% |
| BIOPOR.CO | BioPorto A/S | Healthcare | $93.40M | 1.24 DKK | −16.67% | +2.48% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | Healthcare | $91.93M | 68.60 SEK | −18.62% | +3.94% |
| VISTN.OL | Vistin Pharma ASA | Healthcare | $91.60M | 19.15 NOK | −21.19% | −5.67% |
| EAH.L | ECO Animal Health Group plc | Healthcare | $89.77M | 99.00 GBP | −15.31% | +1.54% |
| 7V0.DE | Novogenia AG | Healthcare | $89.54M | 6.40 EUR | −46.22% | +7.56% |
| OSE.PA | OSE Immunotherapeutics SA | Healthcare | $88.75M | 3.21 EUR | −58.29% | −0.19% |
| NANEXA.ST | Nanexa AB (publ) | Healthcare | $87.59M | 4.63 SEK | −7.40% | +14.46% |
| EQL.ST | EQL Pharma AB (publ) | Healthcare | $87.58M | 27.05 SEK | −75.14% | +34.58% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | Healthcare | $86.56M | 6.40 SEK | −20.60% | +4.23% |
| CREO.L | Creo Medical Group PLC | Healthcare | $85.82M | 12.88 GBP | −30.41% | −5.50% |
| POLB.L | Poolbeg Pharma PLC | Healthcare | $82.41M | 8.60 GBP | −6.52% | +36.51% |
| HIGH.DE | Cantourage Group SE | Healthcare | $81.55M | 6.00 EUR | −12.54% | +5.63% |
| OMDA.OL | Omda AS | Healthcare | $81.21M | 36.00 NOK | −30.50% | −2.17% |
| OBI.L | Ondine Biomedical Inc. | Healthcare | $81.20M | 11.75 GBP | −30.88% | −14.55% |
| INIFY.OL | INIFY Laboratories AB | Healthcare | $81.09M | 7.95 NOK | −3.05% | −3.05% |
| NXTMH.HE | Nexstim Plc | Healthcare | $80.89M | 9.28 EUR | −43.59% | −4.03% |
| AB.PA | AB Science S.A. | Healthcare | $80.25M | 0.74 EUR | −56.01% | +32.68% |
| DICOT.ST | Dicot Pharma AB | Healthcare | $78.22M | 0.21 SEK | −81.86% | +13.89% |
| MDG.WA | Medicalgorithmics S.A. | Healthcare | $76.94M | 28.85 PLN | −32.59% | +15.40% |
| KOO.L | Kooth plc | Healthcare | $72.00M | 146.00 GBP | −23.16% | −3.63% |
| STX.L | Shield Therapeutics plc | Healthcare | $71.97M | 4.85 GBP | −61.20% | −15.65% |
| ALTHX.PA | THX Pharma Société Anonyme | Healthcare | $71.22M | 4.18 EUR | −18.14% | +5.16% |
| ZLNA.OL | Zelluna ASA | Healthcare | $70.31M | 21.70 NOK | −39.39% | −2.25% |
| SAR.L | Sareum Holdings plc | Healthcare | $70.10M | 37.00 GBP | −2.63% | +76.19% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | Healthcare | $68.21M | 13.70 SEK | −30.24% | +13.41% |
| ONCO.ST | Oncopeptides AB (publ) | Healthcare | $68.14M | 1.65 SEK | −74.78% | +2.93% |
| GENT.OL | Gentian Diagnostics ASA | Healthcare | $65.68M | 39.00 NOK | −35.00% | 0.00% |
| MAAT.PA | MaaT Pharma SA | Healthcare | $65.60M | 3.04 EUR | −64.73% | +8.96% |
| LYTIX.OL | Lytix Biopharma ASA | Healthcare | $64.69M | 7.78 NOK | −34.62% | −11.59% |
| AJ91.DE | DocCheck AG | Healthcare | $64.48M | 10.90 EUR | −31.45% | −6.03% |
| HEALTH.HE | Nightingale Health Oyj | Healthcare | $64.18M | 0.93 EUR | −68.00% | +9.95% |
| R0L.F | J Frontier Co.,Ltd. | Healthcare | $64.05M | 10.30 EUR | −44.02% | +10.75% |
| ALGAE.PA | Fermentalg SA | Healthcare | $63.69M | 0.46 EUR | −28.28% | −5.46% |
| SEZI.ST | Senzime AB (publ) | Healthcare | $61.48M | 3.78 SEK | −45.68% | +3.28% |
| HVO.L | hVIVO plc | Healthcare | $59.87M | 6.50 GBP | −40.91% | −10.34% |
| V3V.DE | FamiCord AG | Healthcare | $58.74M | 2.86 EUR | −62.61% | +0.70% |
| ALTHE.PA | Theraclion SA | Healthcare | $55.29M | 0.63 EUR | −49.28% | +6.55% |
| ALSMA.PA | S.M.A.I.O S.A. | Healthcare | $54.96M | 7.60 EUR | −16.48% | −2.56% |
| ALKLH.PA | Klea Holding SA | Healthcare | $54.74M | 0.15 EUR | −50.24% | −4.73% |
| BVC.L | BATM Advanced Communications Ltd. | Healthcare | $54.53M | 12.30 GBP | −38.50% | −3.91% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | Healthcare | $54.52M | 588.00 GBP | −67.33% | −8.12% |
| EPIS-B.ST | Episurf Medical AB (publ) | Healthcare | $53.85M | 0.08 SEK | −72.79% | +37.70% |
| OHGR.L | One Health Group Plc | Healthcare | $53.82M | 292.50 GBP | −2.50% | +10.38% |
| MOB.ST | Moberg Pharma AB (publ) | Healthcare | $53.40M | 10.70 SEK | −24.22% | +9.52% |
| FLUO.ST | FluoGuide A/S | Healthcare | $53.21M | 33.40 SEK | −30.13% | +6.71% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | Healthcare | $52.93M | 14.35 SEK | −58.65% | −8.89% |
| MODU.HE | Modulight Oyj | Healthcare | $52.26M | 1.07 EUR | −26.45% | −0.47% |
| XSPRAY.ST | Xspray Pharma AB (publ) | Healthcare | $51.97M | 10.74 SEK | −83.24% | −35.77% |
| CANTA.ST | Cantargia AB (publ) | Healthcare | $51.16M | 1.91 SEK | −71.02% | +3.24% |
| SVS.MI | Svas Biosana S.p.A. | Healthcare | $50.68M | 8.24 EUR | −23.70% | −5.07% |
| M3V.DE | MeVis Medical Solutions AG | Healthcare | $50.50M | 23.80 EUR | −11.19% | +2.59% |
| HRTIS.HE | Herantis Pharma Oyj | Healthcare | $50.06M | 1.69 EUR | −56.33% | +6.42% |
| AIFORIA.HE | Aiforia Technologies Oyj | Healthcare | $49.78M | 1.17 EUR | −68.63% | +2.99% |
| COIL.L | Coiled Therapeutics plc | Healthcare | $49.30M | 9.50 GBP | −68.33% | −9.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.